The FDA today released a medical device safety communication warning of air-in-line and air embolism risks, as well as the risks of false alarms for such events, associated with infusion pumps, fluid warmers and rapid infusers.
The FDA reinforced the dangers of air-in-line issues, which can lead to potentially life-threatening air embolisms, but also warned of the risks associated with false alarms triggered by air-in-line sensors. Such false alarms could lead to injury due to the possible interruption of infusion therapy, which “could be problematic if crucial medications (for example, Epinephrine) are being infused,” according to the release.
Read the whole story on our sister site, Drug Delivery Business News
